🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Aptorum Group announces annual shareholder meeting details

Published 09/11/2024, 08:40 am
APM
-

Aptorum Group Ltd (NASDAQ:APM), a pharmaceutical company, has announced the details for its upcoming 2024 annual general meeting of shareholders. The meeting is scheduled to take place on December 10, 2024, at 9:00 pm Hong Kong time at the Guangdong Investment (OTC:GGDVY) Tower in Hong Kong.

The company, which is incorporated under the laws of E9 jurisdiction and focuses on the development of pharmaceutical preparations, detailed in its Form 6-K filing with the U.S. Securities and Exchange Commission that the polls for the shareholder meeting will close on December 6, 2024, at 11:59 p.m. EST.

While the filing emphasizes that neither the report nor the exhibits constitute an offer to sell or a solicitation of an offer to buy securities, it does indicate that the information provided will not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, nor will it be incorporated by reference into any filing under the Securities Act of 1933, except as expressly set forth by specific reference in such a filing.

Additionally, this Form 6-K is incorporated by reference into the registration statements of the company on Form S-8 and Form F-3, to the extent that the information is not superseded by subsequent documents or reports filed by the company.

Aptorum Group's business address is listed as 17 Hanover Square (NYSE:SQ), London, with a business phone number of 852 3953 7700. The company's fiscal year-end is December 31.

InvestingPro Insights

As Aptorum Group Ltd (NASDAQ:APM) prepares for its 2024 annual general meeting, investors might benefit from additional financial context. According to InvestingPro data, the company's market capitalization stands at a modest $6.84 million USD, reflecting its current position in the pharmaceutical sector.

InvestingPro Tips highlight that APM is operating with a significant debt burden and may have trouble making interest payments on this debt. This financial strain is evident in the company's performance metrics, with a revenue of just $0.43 million USD in the last twelve months as of Q4 2023, representing a substantial revenue decline of 66.71% over the same period.

Despite these challenges, InvestingPro Tips also indicate that net income is expected to grow this year, and analysts anticipate sales growth in the current year. This potential turnaround could be a critical point of discussion at the upcoming shareholder meeting.

For investors seeking a more comprehensive analysis, InvestingPro offers 16 additional tips for APM, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.